Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum

Molecular Biology and Evolution
Stanislaw J GabryszewskiDavid A Fidock

Abstract

The emergence of drug resistance continuously threatens global control of infectious diseases, including malaria caused by the protozoan parasite Plasmodium falciparum A critical parasite determinant is the P. falciparum chloroquine resistance transporter (PfCRT), the primary mediator of chloroquine (CQ) resistance (CQR), and a pleiotropic modulator of susceptibility to several first-line artemisinin-based combination therapy partner drugs. Aside from the validated CQR molecular marker K76T, P. falciparum parasites have acquired at least three additional pfcrt mutations, whose contributions to resistance and fitness have been heretofore unclear. Focusing on the quadruple-mutant Ecuadorian PfCRT haplotype Ecu1110 (K76T/A220S/N326D/I356L), we genetically modified the pfcrt locus of isogenic, asexual blood stage P. falciparum parasites using zinc-finger nucleases, producing all possible combinations of intermediate pfcrt alleles. Our analysis included the related quintuple-mutant PfCRT haplotype 7G8 (Ecu1110 + C72S) that is widespread throughout South America and the Western Pacific. Drug susceptibilities and in vitro growth profiles of our combinatorial pfcrt-modified parasites were used to simulate the mutational trajectories ac...Continue Reading

References

Jan 1, 1984·Transactions of the Royal Society of Tropical Medicine and Hygiene·T R BurkotI Schneider
Apr 1, 1983·British Journal of Clinical Pharmacology·L L GustafssonF Sjöqvist
Oct 1, 1996·Clinical Pharmacokinetics·J Ducharme, R Farinotti
Feb 15, 2001·The New England Journal of Medicine·A DjimdéC V Plowe
Jun 27, 2001·The American Journal of Tropical Medicine and Hygiene·J F Trape
Oct 25, 2001·Proceedings of the National Academy of Sciences of the United States of America·R K MehlotraP A Zimmerman
Apr 9, 2002·The Lancet Infectious Diseases·Chansuda WongsrichanalaiSteven R Meshnick
Oct 5, 2002·Science·I M HastingsS A Ward
Jun 25, 2004·The Journal of Infectious Diseases·Pedro Paulo VieiraMariano G Zalis
Nov 2, 2004·Nature Medicine·Thomas E Wellems
Jun 10, 2005·The EMBO Journal·Viswanathan LakshmananDavid A Fidock
Aug 3, 2005·Nature Reviews. Genetics·Mark A DePristoDaniel L Hartl
Apr 8, 2006·Science·Daniel M WeinreichDaniel L Hartl
Jan 26, 2007·Nature·Frank J PoelwijkSander J Tans
Apr 19, 2008·Science·N J White
May 20, 2009·Malaria Journal·Leah MwaiAlexis Nzila
Jun 26, 2009·Critical Reviews in Biochemistry and Molecular Biology·Manjunatha KogenaruSander J Tans
Jul 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Elena R LozovskyDaniel L Hartl
Jul 16, 2009·Malaria Journal·Bianca Ervatti GamaMaria de Fátima Ferreira-da-Cruz
Nov 3, 2009·Nature Reviews. Microbiology·Richard T Eastman, David A Fidock
Nov 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Juliana Martha SáThomas E Wellems
Jan 22, 2010·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Ying FuNectarios Klonis
Feb 11, 2010·Antimicrobial Agents and Chemotherapy·Sean GriffingVenkatachalam Udhayakumar
Apr 20, 2010·International Journal for Parasitology·Cecilia P SanchezMichael Lanzer
May 15, 2010·Science·M J Mackinnon, K Marsh
May 21, 2010·PLoS Pathogens·Stephanie G ValderramosDavid A Fidock
Jun 23, 2010·Malaria Journal·Bianca E GamaMaria de Fátima Ferreira-da-Cruz
Jun 26, 2010·Molecular Biology and Evolution·Kyle M BrownDaniel L Hartl
Jul 29, 2010·The Journal of Infectious Diseases·Miriam K LauferChristopher V Plowe
Aug 3, 2010·Methods in Molecular Biology·Sophie H AdjalleyDavid A Fidock
Sep 3, 2010·Molecular Microbiology·Jigar J PatelMichael T Ferdig

❮ Previous
Next ❯

Citations

Feb 10, 2017·Trends in Parasitology·Sarah K VolkmanDaniel L Hartl
Mar 16, 2017·Current Opinion in Biotechnology·Marta Lukačišinová, Tobias Bollenbach
Aug 31, 2016·Nature Microbiology·Alan H FairlambAndrew P Waters
Sep 30, 2020·PLoS Computational Biology·Zachary R SailerMichael J Harms
Aug 24, 2018·Scientific Reports·Duangkamon BunditvorapoomThanat Chookajorn
Feb 24, 2021·Journal of Medicinal Chemistry·Aloysus LawongMargaret A Phillips
Apr 24, 2021·Journal of Molecular Biology·Jonathan KimFilippo Mancia
Jun 16, 2021·Communications Biology·Katrina A Button-SimonsIan H Cheeseman
Sep 13, 2017·Biochemistry·Matthew R HassettPaul D Roepe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.